Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Byington, RP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pitt, B; Byington, RP; Furberg, CD; Miller, ME; Riley, W; Hunninghake, DB; Mancini, GBJ
      Does amlodipine increase cancer incidence? Response

      CIRCULATION
    2. Pitt, B; Byington, RP; Furberg, CD; Hunninghake, DB; Mancini, GBJ; Miller, ME; Riley, W
      Confusing press releases and the PREVENT study - Response

      CIRCULATION
    3. Byington, RP; Davis, BR; Plehn, JF; White, HD; Baker, J; Cobbe, SM; Shepherd, J
      Reduction of stroke events with pravastatin - The Prospective Pravastatin Pooling (PPP) Project

      CIRCULATION
    4. Byington, RP
      Beta-blocker heart attack trial

      CLINICAL TRIALS IN HYPERTENSION
    5. Pitt, B; Byington, RP; Furberg, CD; Hunninghake, DB; Mancini, GBJ; Miller, ME; Riley, W
      Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

      CIRCULATION
    6. Byington, RP
      Cholesterol-lowering trials with carotid ultrasonographic outcomes

      CHOLESTEROL-LOWERING THERAPY
    7. Byington, RP; Evans, GW; Espeland, MA; Applegate, WB; Hunninghake, DB; Probstfield, J; Furberg, CD
      Effects of lovastatin and warfarin on early carotid atherosclerosis - Sex-specific analyses

      CIRCULATION
    8. MILLER M; BYINGTON RP; HUNNINGHAKE D; FURBERG CD; PITT B
      LIPID-LOWERING THERAPY IN CAD PATIENTS AT ACADEMIC MEDICAL-CENTERS - UNDERTREATMENT AND EVIDENCE OF A GENDER-GAP

      Journal of the American College of Cardiology
    9. TATTI P; PAHOR M; BYINGTON RP; DIMAURO P; GUARISCO R; STROLLO G; STROLLO F
      OUTCOME RESULTS OF THE FOSINOPRIL VERSUS AMLODIPINE CARDIOVASCULAR EVENTS RANDOMIZED TRIAL (FACET) IN PATIENTS WITH HYPERTENSION AND NIDDM

      Diabetes care
    10. BYINGTON RP; FURBERG CD; CRAVEN TE; PAHOR M; SOWERS JR
      ISRADIPINE IN PREDIABETIC HYPERTENSIVE SUBJECTS

      Diabetes care
    11. CROUSE JR; BYINGTON RP; FURBERG CD
      HMG-COA REDUCTASE INHIBITOR THERAPY AND STROKE RISK REDUCTION - AN ANALYSIS OF CLINICAL-TRIALS DATA (VOL 138, PG 11, 1998)

      Atherosclerosis (Amsterdam)
    12. CROUSE JR; BYINGTON RP; FURBERG CD
      HMG-COA REDUCTASE INHIBITOR THERAPY AND STROKE RISK REDUCTION - AN ANALYSIS OF CLINICAL-TRIALS DATA

      Atherosclerosis
    13. CROUSE JR; BYINGTON RP; HOEN HM; FURBERG CD
      LOWERING OF CHOLESTEROL LEVELS AND THE RISK OF STROKE - REPLY

      Archives of internal medicine
    14. BYINGTON RP; CRAVEN TE; FURBERG CD; PAHOR M
      ISRADIPINE, RAISED GLYCOSYLATED HEMOGLOBIN, AND RISK OF CARDIOVASCULAR EVENTS

      Lancet
    15. APPLEGATE WB; FURBERG CD; BYINGTON RP; GRIMM R
      THE TICENTER-ISRADIPINE-DIURETIC-ATHEROSCLEROSIS-STUDY (MIDAS)

      JAMA, the journal of the American Medical Association
    16. TATTI P; PAHOR M; BYINGTON RP; DIMAURO P; GUARISCO R; STROLLO F
      RESULTS OF THE FOSINOPRIL AMLODIPINE CARDIOVASCULAR EVENTS TRIAL (FACET) IN HYPERTENSIVE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS (NIDDM)

      Circulation
    17. CROUSE JR; BYINGTON RP; HOEN HM; FURBERG CD
      REDUCTASE INHIBITOR MONOTHERAPY AND STROKE PREVENTION

      Archives of internal medicine
    18. BYINGTON RP; MILLER ME; HERRINGTON D; RILEY W; PITT B; FURBERG CD; HUNNINGHAKE DB; MANCINI GBJ
      RATIONALE, DESIGN, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE RANDOMIZED EVALUATION OF THE VASCULAR EFFECTS OF NORVASC TRIAL (PREVENT)

      The American journal of cardiology
    19. DOLECEK TA; BRADHAM KH; ESPELAND MA; MARGITIC SE; BYINGTON RP; HOEN H; KAPPELLE LJ
      MAXIMIZING RECRUITMENT EFFORTS IN A DRUG LIPID-LOWERING TRIAL WITH DIETARY INTERVENTION TO LOWER LDL CHOLESTEROL

      Controlled clinical trials
    20. CROUSE JR; BYINGTON RP; FURBERG CD
      REDUCTASE INHIBITOR MONOTHERAPY PREVENTS STROKE

      Circulation
    21. ADAMS HP; BYINGTON RP; HOEN H; DEMPSEY R; FURBERG CD
      EFFECT OF CHOLESTEROL-LOWERING MEDICATIONS ON PROGRESSION OF MILD ATHEROSCLEROTIC LESIONS OF THE CAROTID ARTERIES AND ON THE RISK OF STROKE

      Cerebrovascular diseases
    22. BYINGTON RP; FURBERG CD
      REVERSING RISK IN CORONARY-DISEASE

      Lancet
    23. BYINGTON RP; JUKEMA JW; SALONEN JT; PITT B; BRUSCHKE AV; HOEN H; FURBERG CD; MANCINI J
      REDUCTION IN CARDIOVASCULAR EVENTS DURING PRAVASTATIN THERAPY - POOLED ANALYSIS OF CLINICAL EVENTS OF THE PRAVASTATIN ATHEROSCLEROSIS INTERVENTION PROGRAM

      Circulation
    24. PROBSTFIELD JL; MARGITIC SE; BYINGTON RP; ESPELAND MA; FURBERG CD
      RESULTS OF THE PRIMARY OUTCOME MEASURE AND CLINICAL EVENTS FROM THE ASYMPTOMATIC CAROTID-ARTERY PROGRESSION STUDY

      The American journal of cardiology
    25. BYINGTON RP; FURBERG CD; CROUSE JR; ESPELAND MA; BOND MG
      PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)

      The American journal of cardiology
    26. FURBERG CD; PITT B; BYINGTON RP; PARK JS; MCGOVERN ME
      REDUCTION IN CORONARY EVENTS DURING TREATMENT WITH PRAVASTATIN

      The American journal of cardiology
    27. FURBERG C; BYINGTON RP; BAKER JL; COBBE SM; DAVIS B; FORD I; GLASZIOU P; HAWKINS CM; KEECH AC; MACMAHON S; MOYE L; PACKARD C; PFEFFER MA; SACKS FM; SHEPHERD J; SIMES J; TONKIN A; MELLIES M; MCGOVERN M; NICHOLAS S; ANDERSON S; PARK JS; BARNHART M; FORTUNATO J
      DESIGN, RATIONALE, AND BASE-LINE CHARACTERISTICS OF THE PROSPECTIVE PRAVASTATIN POOLING (PPP) PROJECT - A COMBINED ANALYSIS OF 3 LARGE-SCALE RANDOMIZED TRIALS - LONG-TERM INTERVENTION WITH PRAVASTATIN IN ISCHEMIC-DISEASE (LIPID), CHOLESTEROL AND RECURRENT EVENTS (CARE), AND WESTOF SCOTLAND CORONARY PREVENTION STUDY (WOSCOPS)

      The American journal of cardiology
    28. CROUSE JR; BYINGTON RP; BOND MG; ESPELAND MA; CRAVEN TE; SPRINKLE JW; MCGOVERN ME; FURBERG CD
      PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)

      The American journal of cardiology
    29. CROUSE JR; BYINGTON RP; BOND MG; ESPELAND MA; CRAVEN TE; SPRINKLE JW; MCGOVERN ME; FURBERG CD
      PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (VOL75, PG 455, 1995)

      The American journal of cardiology
    30. FURBERG CD; BYINGTON RP; CRAVEN TE
      LESSONS LEARNED FROM CLINICAL-TRIALS WITH ULTRASOUND END-POINTS

      Journal of internal medicine
    31. GILLIS BP; CAGGIULA AW; JONES FL; MAURER E; MEEHAN RM; YAMAMOTO ME; STRIKER GE; KUSEK JW; AGODOA LY; ANDERSON A; KLAHR S; LEVEY AS; VARDAMAN M; BURKART TJM; FURBERG CD; FELTS J; MOORE M; ROCCO M; WARREN S; BEARDEN B; STARKEY C; DOLECEK TA; HARVEY J; POOLE D; DAHLQUIST S; DOROSHENKO L; BRADHAM K; WEST D; AGOSTINO J; COLE LR; BAKER B; HAIRSTON K; LAZARUS M; STEINMAN TTI; SEIFTER JJ; DESMOND MA; FIORENZO MA; CHIAVACCI AT; METALIDES T; KORZECRAMIREZ D; GOULD SL; PICKETT V; PORUSH JG; FAUBERT PF; SPITALEWITZ S; FAUBERT JS; ZIMMER GS; SAUM DL; BLOCK M; WOEL J; ROSE MF; DENNIS VW; SCHWAB TSJ; MINDA SA; CONDON SM; JENKS BF; ECKARD L; GEDON G; MITCH WE; MARONI BJ; ENGLAND BK; SOUCIE M; PEDERSEN MF; AKPELE L; CALLAHN P; HALL B; KOPPLE JD; ADLER SG; HIRSCHBERG R; DICHIRO J; SNIDER K; DEVINE W; MCKAY S; MCDONALD JM; CARTER J; NELSON WJ; COGGINS CH; DWYER JT; MCLAUGHLIN ML; GRONICH J; KING AJ; STOLLAR C; RAIZMAN D; CASTALDO L; DESIMONE D; EFSTATHION A; YONKER K; FINE JA; HUGGINS N; MARTIN A; BALDI S; MOLESKE C; FURLONG D; HEBERT LA; NAHMAN NS; DRIVER V; COSIO MJ; HARTMAN JA; LEVY CS; LONDERGAN D; GILLIGAN M; BECKMAN TJ; MILLER J; SMITH E; TISHER CC; PETERSON JC; WINGO CS; FINLAY A; PARRIS ES; IVEY G; GREGORY P; HOFFINGER R; GARCIA D; PRESTON C; HUNSICKER LG; BERTOLATUS JA; LIM V; SNETSELAAR L; WELCH B; BROOKS LL; HOLLINGER DL; LICHTY I; MUELLER DK; EASTIN S; TANNA A; STEELE J; RIECK K; BOURGOIGNIE J; ROTH D; GREEN DF; DEVALDERRAMA CO; MERRILL D; DEVELASCO A; GARCON M; ROJAS C; ZARAGOZA M; BARTON A; MASSRY SG; AKMAL M; FADDA G; SMORGORZERSKI M; KIEFER S; RAUCH S; EYERMAN M; KIGAWA L; LIFSCHITZ MD; NOLAN CR; GOUGE S; BAKRIS G; YOUNG E; ARMES C; WARNER C; TANSEY A; FIORES MO; DELEA CS; TESCHAN PE; HAKIM RM; BREYER JA; SCHULMAN G; ROGERS NL; POWERS SN; MCLEROY S; FISCHER S; DEERE M; CUTLER EM; BECK GJ; WILLIAMS GW; GASSMAN JJ; GREENE T; SCHLUCHTER MD; BERG RL; BROWN M; CHU L; DRABIK MJ; FATICA KJ; LAMBDIN KE; LEATHERMAN JR; MCPHERSON JA; MIDCALF V; MOORE B; SWINDERMAN DM; WEBB L; YANCHAR KA; MILAS NC; AMOROSO WP; AVERBACH FA; COYNE T; GILLIS B; MAURER EA; MEEHAN RJ; NAUJELIS JA; OLSON MB; SCHERCH LK; STANO E; CHUMLEA WC; WING RR; STEGINK LD; BRUMMEL MC; VANLENTE F; WALETZKY JA; ERDEI LM; SOUTH CA; SPAGNOLA C; OLAUGHLIN C; PROUDFIT WL; UNDERWOOD DA; HALL PM; ROLIN HA; PEXA DS; JONES E; BASCH M; DAMICO G; DIRKS JH; GRANTHAM J; HARPER AE; PETERS K; STEIN JH; PELLEGRINO ED; VANYPERSELE C; MYERS BD; GRIZZLE JE; HAWKINS CM; HOLLIDAY MA; RUDMAN D; YOUNG DS; YOUNG V; LUKE R; KAPLAN RM; BYINGTON RP
      FEATURES OF THE NUTRIENT DATABASE AND ANALYSIS SYSTEM FOR THE MODIFICATION OF DIET IN RENAL-DISEASE STUDY

      Controlled clinical trials
    32. BYINGTON RP; EVANS GW; APPLEGATE WB; IFURBERG CD
      PREDICTORS OF CAROTID ATHEROSCLEROSIS PROGRESSION

      Circulation
    33. BYINGTON RP; EVANS GW; APPLEGATE WB; IFURBERG CD
      PREDICTORS OF CAROTID ATHEROSCLEROSIS PROGRESSION

      Circulation
    34. DOLECEK TA; FURBERG CD; EVANS GW; BRADHAM KH; BYINGTON RP; BILLER J; KRITCHEVSKY S
      INFLUENCES OF DIETARY-FAT INTAKE ON PROGRESSION OF CAROTID-ARTERY WALL THICKNESS MEASURED BY B-MODE ULTRASOUND IN A DRUG LIPID-LOWERING TRIAL

      Circulation
    35. DOLECEK TA; FURBERG CD; EVANS GW; BRADHAM KH; BYINGTON RP; BILLER J; KRITCHEVSKY S
      INFLUENCES OF DIETARY-FAT INTAKE ON PROGRESSION OF CAROTID-ARTERY WALL THICKNESS MEASURED BY B-MODE ULTRASOUND IN A DRUG LIPID-LOWERING TRIAL

      Circulation
    36. FURBERG CD; ADAMS HP; APPLEGATE WB; BYINGTON RP; ESPELAND MA; HARTWELL T; HUNNINGHAKE DB; LEFKOWITZ DS; PROBSTFIELD J; RILEY WA; YOUNG B
      EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS

      Circulation
    37. FURBERG CD; BYINGTON RP; CROUSE JR; ESPELAND MA
      PRAVASTATIN, LIPIDS, AND MAJOR CORONARY EVENTS

      The American journal of cardiology
    38. FURBERG CD; BYINGTON RP
      ACAPS - EFFECTS OF LOVASTATIN ON PROGRESSION OF CAROTID ATHEROSCLEROSIS AND CLINICAL EVENTS

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 14:39:00